Effects of griseofulvin on enzymes associated with phase I and II of drug metabolism.
D000818:Animals; D001189:Aryl Hydrocarbon Hydroxylases / Q000032:analysis; D003577:Cytochrome P-450 Enzyme System / Q000032:analysis; D006118:Griseofulvin / Q000494:pharmacology*; D006418:Heme / Q000378:metabolism; D008297:Male; D008797:Metyrapone / Q000378:metabolism; D008862:Microsomes, Liver / Q000201:enzymology; D009251:NADPH-Ferrihemoprotein Reductase / Q000032:analysis; D004364:Pharmaceutical Preparations / Q000378:metabolism*; D051381:Rats; D011919:Rats, Inbred Strains
D004364:Pharmaceutical Preparations; D006118:Griseofulvin; D006418:Heme; D003577:Cytochrome P-450 Enzyme System; D001189:Aryl Hydrocarbon Hydroxylases; D009251:NADPH-Ferrihemoprotein Reductase; D008797:Metyrapone